Science Library · GH releasing peptide

GHRP-6 the science.

GHRP-6 (growth hormone-releasing peptide 6) is one of the original synthetic hexapeptides developed to study growth-hormone release. It acts on the growth-hormone-secretagogue (ghrelin) receptor and was among the molecules that led researchers to discover ghrelin itself. Research includes preclinical work and early-phase human studies. The summary below reflects published research.

View the GHRP-6 product page

6 aa
Peptide length
GHS-R1a
Primary target
Human studies
Evidence stage
Investigational
Regulatory status
GHRP-6 research vial

How it works

Mechanism at a glance

Compound
GHRP-6
Action
Agonizes the ghrelin receptor
Effect
Stimulates GH release
Studied in
Healthy-volunteer studies

Evidence to date

Evidence to date: preclinical plus early-phase human studies. Not FDA-approved.

What it is

GHRP-6 is a synthetic six-amino-acid peptide (His-D-Trp-Ala-Trp-D-Phe-Lys) and a foundational member of the growth-hormone-releasing-peptide family. It does not act on the GHRH receptor; instead it binds the growth-hormone-secretagogue receptor (GHS-R1a). Its study was historically important — the search for the natural ligand of the receptor GHRP-6 activated ultimately led to the identification of ghrelin.

In research, GHRP-6 serves as a classic tool compound for dissecting the GHS-receptor pathway and its interaction with GHRH signaling. It is an investigational compound, not an approved medicine.

The pathway under study: the ghrelin (GHS) receptor

GHRP-6 research is organized around the ghrelin-receptor route to GH release:

  • GHS-R1a activation — binding the ghrelin receptor on pituitary somatotrophs is studied for how it evokes GH secretion.
  • GHRH interaction — investigators examine the amplified GH response when GHRP-6 is combined with GHRH, a hallmark of GHS-receptor research.
  • Receptor pharmacology — GHRP-6 is widely used to characterize GHS-receptor binding and downstream signaling in cell and tissue models.

What research has explored

GHRP-6 has an extensive preclinical literature plus early-phase human research:

  • GH-receptor blockade study (2001). A study in the Journal of Clinical Endocrinology & Metabolism examined GHRP-6-mediated GH release in humans under GH-receptor blockade, probing the feedback architecture of the axis.
  • Diagnostic combination testing (2005). Research in the European Journal of Endocrinology evaluated a GHRH/GHRP-6 combination as a provocative test for GH deficiency.

These human studies are early-phase and investigational. GHRP-6 is not FDA-approved, and this material is supplied for research use only.

Current state of the evidence

GHRP-6 is an investigational ghrelin-receptor agonist with a long history as a research tool. Published evidence includes early-phase human studies alongside extensive preclinical work, but it is not FDA-approved and no approved indication, dosing, or therapeutic claim applies. GHRP-6 is supplied strictly as a research material for laboratory investigation.

Compound Snapshot

At a glance

Identity

What is GHRP-6?

Type
Synthetic hexapeptide (GHRP family)
Sequence
His-D-Trp-Ala-Trp-D-Phe-Lys
Amino acids
6
Primary target
Growth-hormone-secretagogue receptor (GHS-R1a)
Research family
GH secretagogue
Use classification
Research Use Only
PubChem Database

Evidence base

Research maturity

Investigational Human study data Not FDA-approved
Maturity Clinical (early phase) Extensive preclinical work plus published early-phase human studies; still investigational.
Status Not FDA-approved No approved indication, dosing, or therapeutic claim. Supplied for research use only.

Sources & References

Peer-reviewed research and database records

J. Clinical Endocrinology & Metabolism / PubMed

Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance

2001 · PMID 11158013 · DOI 10.1210/jcem.86.2.7173 View Source

European Journal of Endocrinology / PubMed

The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese patients

2005 · PMID 15817913 · DOI 10.1530/eje.1.01887 View Source

PubChem

GHRP-6 compound search

NIH PubChem lookup for molecular identity and structure records. View Source

PubMed

GHRP-6 literature search

NCBI PubMed index for primary papers, reviews, and PMID-linked records. View Source

For research use only. Not for human or veterinary use. These products have not been evaluated by the FDA. Nothing on this page is medical advice or a therapeutic claim.

Catalog

Explore GHRP-6.

View product